## Abstract ## Introduction Classical Hodgkin's Lymphoma (cHL) has been frequently associated with Epstein–Barr virus (EBV), which can be found in a latent pattern in Reed‐Sternberg (RS) cells. However, the impact of the presence of EBV in RS cells and its prognosis are still controversial. We ana
The effect of Epstein–Barr virus status on clinical outcome in Hodgkin’s lymphoma
✍ Scribed by J. M. Kwon; Y. H. Park; J. H. Kang; K. Kim; Y. H. Ko; B. Y. Ryoo; S. S. Lee; S. I. Lee; H. H. Koo; W. S. Kim
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 124 KB
- Volume
- 85
- Category
- Article
- ISSN
- 0939-5555
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Immunosuppressed patients who develop non-Hodgkin's lymphoma (NHL) have abnormal antibody responses against the Epstein-Barr virus (EBV) prior to the diagnosis of malignancy. To see if this is also true of "spontaneous" cases in the general population, we undertook a collaborative serologic cas
## Abstract The role of Epstein‐Barr virus (EBV) in Hodgkin's lymphoma (HL) etiology remains unresolved as EBV is detected in only some HL tumors and few studies have tried to reconcile its presence with factors suggesting viral etiology (__e.g.,__ childhood social class, infection history). In a p
## Abstract To assess the role of the Epstein‐Barr virus (EBV) latent membrane protein 1 (LMP1) gene in the development of Hodgkin's lymphoma (HL), the polymorphism of this gene in EBV isolates from different geographic locations was analyzed. A 497 bp fragment spanning LMP1 gene exons 1 and 2 was
Hodgkin's disease (HD) is associated with the Epstein-Barr virus (EBV) in approximately half of cases. This is a report of a case of nodular sclerosing HD of the B-cell type that was associated with EBV in the initial manifestation, but was found to be EBV-negative in the relapse of the tumour. Both